We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.34B
AUM Growth
-$657M
Cap. Flow
-$485M
Cap. Flow %
-11.17%
Top 10 Hldgs %
42.98%
Holding
79
New
16
Increased
24
Reduced
23
Closed
15

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$93M
3
BHC icon
Bausch Health
BHC
+$72.6M
4
CPAY icon
Corpay
CPAY
+$65.7M
5
VMC icon
Vulcan Materials
VMC
+$64.8M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$185M
2
AGN
Allergan Inc
AGN
+$144M
3
MCK icon
McKesson
MCK
+$132M
4
BKNG icon
Booking.com
BKNG
+$130M
5
MDVN
MEDIVATION, INC.
MDVN
+$98.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.04%
2 Communication Services 18.99%
3 Materials 9.44%
4 Technology 8.93%
5 Energy 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPAY icon
26
Corpay
CPAY
$24.8B
$67.8M 1.56%
+477,040
New +$65.7M
TIBX
27
DELISTED
TIBCO SOFTWARE INC
TIBX
$66.1M 1.52%
2,799,369
-462,718
-14% -$9.46M
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
$57.6M 1.33%
1,270,209
+825,475
+186% +$34.5M
TCOM icon
29
Trip.com Group
TCOM
$28.3B
$53.2M 1.22%
1,874,654
-403,790
-18% -$12.8M
VIPS icon
30
Vipshop
VIPS
$7.06B
$45.5M 1.05%
+2,409,360
New +$49.6M
ACOR
31
DELISTED
Acorda Therapeutics
ACOR
$41.5M 0.96%
+10,217
New +$38.3M
KPTI icon
32
Karyopharm Therapeutics
KPTI
$166M
$39.3M 0.91%
75,057
+30,868
+70% +$17.4M
MCK icon
33
McKesson
MCK
$100B
$36.1M 0.83%
185,365
-684,748
-79% -$132M
MDVN
34
DELISTED
MEDIVATION, INC.
MDVN
$35.5M 0.82%
717,170
-2,319,664
-76% -$98.6M
HNT
35
DELISTED
HEALTH NET INC
HNT
$35M 0.8%
757,962
-71,795
-9% -$3.19M
TWX
36
DELISTED
Time Warner Inc
TWX
$32.4M 0.74%
+430,215
New +$33.3M
KYTH
37
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$32.1M 0.74%
978,752
+26,037
+3% +$917K
ZSPH
38
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$28.6M 0.66%
+729,044
New +$24.1M
HUM icon
39
Humana
HUM
$46.2B
$28.5M 0.66%
218,569
+46,955
+27% +$5.97M
ANAC
40
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$24.8M 0.57%
1,014,291
-46,870
-4% -$952K
THC icon
41
Tenet Healthcare
THC
$21.1B
$23.1M 0.53%
388,944
-192,770
-33% -$10.8M
A icon
42
Agilent Technologies
A
$38.7B
$22.8M 0.52%
558,368
-2,053,230
-79% -$83.8M
OCR
43
DELISTED
OMNICARE INC
OCR
$22.5M 0.52%
361,147
+91,849
+34% +$5.84M
OREX
44
DELISTED
Orexigen Therapeutics, Inc.
OREX
$20.6M 0.47%
483,832
+23,336
+5% +$1.25M
MDCO
45
DELISTED
Medicines Co
MDCO
$19.8M 0.46%
889,114
+412,180
+86% +$10.5M
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$4.36B
$13.9M 0.32%
560,786
-1,071,389
-66% -$25.1M
HOLX
47
DELISTED
Hologic
HOLX
$13.4M 0.31%
+552,764
New +$14M
ALDR
48
DELISTED
Alder Biopharmaceuticals
ALDR
$13.1M 0.3%
1,034,030
+296,003
+40% +$4.47M
RLYP
49
DELISTED
RELYPSA INC COM
RLYP
$12.4M 0.29%
+589,492
New +$14.3M
CAH icon
50
Cardinal Health
CAH
$53.9B
$11.3M 0.26%
+150,484
New +$10.9M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2014 Portfolio in Review

As of Q3 2014, PFM Health Sciences held 79 positions worth $4.34B, down 13% from $5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $485M in Q3 2014, closing 15 positions and reducing 23 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Communication Services and Materials.

Against the trend, PFM Health Sciences opened a new position in Corpay worth $67.8M.

  • PFM Health Sciences's largest Q3 2014 buy was Corpay: 477,040 shares worth $67.8M.
  • PFM Health Sciences added most to Baidu in Q3 2014, an estimated $94.7M increase.
  • PFM Health Sciences's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $144M.
  • PFM Health Sciences fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $185M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $4.34B portfolio in Q3 2014.
  • PFM Health Sciences opened 16 new positions and closed 15 in Q3 2014.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $4.34B.

Based on PFM Health Sciences's 13F filing for Q3 2014, filed 14 Nov 2014.